InsidersTradesSigma
Follow the AN2 Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, AN2 Therapeutics, Inc. has logged 134 reports. Market capitalisation: €210.6m. The latest transaction was reported on 4 September 2026 (Cession). Among the most active insiders: Aziz Kabeer. All data is accessible without an account.
134
Insider Decl.
n/a
Thresholds
€17m
21 ops.
Buy Volume
€15m
51 ops.
Sell Volume
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
Declarations134 total
272 shares@ US$5.530.0007% mcap49.8% of flowCommon StockSEC:0001193125-26-383697:0
2,098 shares@ US$5.53Common StockSEC:0001193125-26-380595:0
Canonical exit: 30 Nov 2026 (T+90)
16,696 shares@ US$6.00820.045% mcap1.5% of flowCommon StockSEC:0001193125-26-357225:0
18,706 shares@ US$6.00820.050% mcap1.7% of flowCommon StockSEC:0001193125-26-357225:1
1,012,000 shares@ US$6.00822.69% mcap95.9% of flowCommon StockSEC144:0001972481-26-000263
405,880 shares0Common StockSEC:0001193125-26-351801:0
766 shares0Common StockSEC:0001193125-26-301165:0
2,789 shares0Common StockSEC:0001193125-26-301166:0
2,852 shares0Common StockSEC:0001193125-26-301167:0
5,945 shares@ US$4.1720.011% mcap41.4% of flowCommon StockSEC:0001193125-26-301092:0
265 shares@ US$4.430.0006% mcap100.0% of flowCommon StockSEC:0001193125-26-253622:0
1,192 shares0Common StockSEC:0001193125-26-151626:0
3,775 shares0Common StockSEC:0001193125-26-151628:0
3,775 shares0Common StockSEC:0001193125-26-151632:0
327 shares@ US$1.0622.7% of flowCommon StockSEC:0001193125-26-094490:0
48,375 shares0Common StockSEC:0001193125-26-064166:0
112,250 shares0Common StockSEC:0001193125-26-064151:0
38,000 shares0Common StockSEC:0001193125-26-064141:0
50,000 shares0Common StockSEC:0001193125-26-064176:0
11,560 shares0Common StockSEC:0001193125-26-013041:0
3,650 shares0Common StockSEC:0001193125-26-013038:0
11,560 shares0Common StockSEC:0001193125-26-013035:0
3,604 shares@ US$1.00347.5% of flowCommon StockSEC:0001193125-26-006770:0
25 of 134 declarations
关于 AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. 是一家生物制药公司，专注于开发传染病治疗方法。该公司在纳斯达克上市，股票代码为 ANTX。